This session is intended for intermediate learners with an understanding of the basic principles of meaningful, safe, and inclusive patient and public engagement.
Following this session, attendees will be able to:
• Describe key steps in establishing an advisory group for patient and public engagement;
• Develop a plan for effective advisory group meetings in the first year; and
• Maintain advisory group activities of the course of a health research or services project.
- The document provides sales forecasts for Esoz 20, an esomeprazole magnesium tablet, for the first year in quarterly projections. It estimates sales of Rs. 2.5 crore for the year with sales increasing each month and quarter as penetration increases.
- A promotional budget of Rs. 30 lakh is allocated equally across the 4 quarters to market the brand to gastroenterologists, general physicians, surgeons and gynaecologists in metro and class 1/2 cities.
- Key activities include product sampling, branding materials, and print advertisements. Pricing is set at Rs. 15.93 per tablet with a company margin of 60% after trade discounts.
Role of Business Development in Pharmaceuticals (Generic Product Business)Muhammad Ali Jehangir
Role of Business Development in Pharmaceuticals (Generic Product Business)
For New Updated Slide Deck: https://www.slideshare.net/alijehangir/business-development-licensing-overview-150008616
The document discusses launching a new Itraconazole brand called Brintra. It analyzes the large and growing anti-fungal market in India, noting Itraconazole is the top prescribed drug. It examines competitors and finds the top brands have low prices and broad prescriber reach. The SWOT analysis notes strengths in market size and demand, but weaknesses in an overcrowded market. It suggests positioning Brintra through a new formulation technology and price advantage to effectively compete.
This document discusses strategies for launching new products. It covers several key points:
1. Successful product launching depends on coordination across functions and preparation.
2. Strategic decisions for launching include identifying customers, product positioning, and developing an appropriate marketing mix.
3. Tactical decisions involve the "4 Ps" of marketing - product, price, place (distribution), and promotion.
4. The document provides an overview of different product life cycle stages and strategies for each stage.
This document provides a business plan for Losartan Potassium (Losartan) in Bangladesh for 2015. It summarizes hypertension prevalence data from various sources, showing about 20% of people in Bangladesh have hypertension. The cardiovascular drug market is growing at 11% annually and Losartan has a 29.24% share of the antihypertensive market. The objectives for 2015 are to achieve 10% sales growth, a 4.9% market share, and reach the number 3 market position for Losartan. The strategies proposed include increasing prescriptions from specialty physicians like cardiologists and improving performance in metro areas through targeted promotional initiatives.
Accrufer is an oral iron replacement product approved by the FDA in July 2019 to treat iron deficiency anemia. It contains 30 mg of iron complexed with maltol in capsule form, taken twice daily. The iron and maltol dissociate and are absorbed separately in the gastrointestinal tract. Common side effects include flatulence, diarrhea, and constipation. It is contraindicated in patients with hypersensitivity, hemochromatosis, or active inflammatory bowel disease.
- The document provides sales forecasts for Esoz 20, an esomeprazole magnesium tablet, for the first year in quarterly projections. It estimates sales of Rs. 2.5 crore for the year with sales increasing each month and quarter as penetration increases.
- A promotional budget of Rs. 30 lakh is allocated equally across the 4 quarters to market the brand to gastroenterologists, general physicians, surgeons and gynaecologists in metro and class 1/2 cities.
- Key activities include product sampling, branding materials, and print advertisements. Pricing is set at Rs. 15.93 per tablet with a company margin of 60% after trade discounts.
Role of Business Development in Pharmaceuticals (Generic Product Business)Muhammad Ali Jehangir
Role of Business Development in Pharmaceuticals (Generic Product Business)
For New Updated Slide Deck: https://www.slideshare.net/alijehangir/business-development-licensing-overview-150008616
The document discusses launching a new Itraconazole brand called Brintra. It analyzes the large and growing anti-fungal market in India, noting Itraconazole is the top prescribed drug. It examines competitors and finds the top brands have low prices and broad prescriber reach. The SWOT analysis notes strengths in market size and demand, but weaknesses in an overcrowded market. It suggests positioning Brintra through a new formulation technology and price advantage to effectively compete.
This document discusses strategies for launching new products. It covers several key points:
1. Successful product launching depends on coordination across functions and preparation.
2. Strategic decisions for launching include identifying customers, product positioning, and developing an appropriate marketing mix.
3. Tactical decisions involve the "4 Ps" of marketing - product, price, place (distribution), and promotion.
4. The document provides an overview of different product life cycle stages and strategies for each stage.
This document provides a business plan for Losartan Potassium (Losartan) in Bangladesh for 2015. It summarizes hypertension prevalence data from various sources, showing about 20% of people in Bangladesh have hypertension. The cardiovascular drug market is growing at 11% annually and Losartan has a 29.24% share of the antihypertensive market. The objectives for 2015 are to achieve 10% sales growth, a 4.9% market share, and reach the number 3 market position for Losartan. The strategies proposed include increasing prescriptions from specialty physicians like cardiologists and improving performance in metro areas through targeted promotional initiatives.
Accrufer is an oral iron replacement product approved by the FDA in July 2019 to treat iron deficiency anemia. It contains 30 mg of iron complexed with maltol in capsule form, taken twice daily. The iron and maltol dissociate and are absorbed separately in the gastrointestinal tract. Common side effects include flatulence, diarrhea, and constipation. It is contraindicated in patients with hypersensitivity, hemochromatosis, or active inflammatory bowel disease.
ROLE & RESPONSIBILITIES OF A MEDICAL REPRESENTATIVE.pptxManish13261326
The document discusses the role and responsibilities of a medical representative. Their key responsibilities include achieving sales targets, promoting products to doctors and retailers, identifying new business opportunities, providing product knowledge and feedback from customers. Medical representatives must have excellent communication, presentation, and interpersonal skills. They are expected to build brands, generate prescriptions and establish good relationships with customers. The document also outlines the expectations that doctors have of pharmaceutical companies, such as regular visits, scientific information and satisfying patient needs. Medical representatives use various promotional methods like visual aids, literature, samples and gifts to promote pharmaceutical products.
This document discusses strategies for launching new pharmaceutical brands. It outlines that successful product launching depends on coordination across functions. The purpose is to build sales. A launching strategy consists of marketing decisions, activities, and product attributes to present the product to its target market. The objectives are to generate income. Key aspects of launching strategy include being first to market, a first follower, or delayed entrant. Marketing decisions include market entry strategy, product positioning, and marketing mix. Strategic decisions involve company strategy, product strategy, market strategy, and competitive strategy. Tactical decisions involve the marketing mix of product, price, promotion, and distribution. Success depends on customer performance, financial performance, and technical performance. The document provides details on various strategic
This document discusses various marketing strategies for pharmaceutical products. It begins with defining key terminology related to drugs, such as generic, branded, patented, and over-the-counter medicines. It then outlines general marketing strategies such as market expansion, market share growth, niche markets, and market exit. Specific strategies for market leaders, challengers, followers, and niche players are also discussed. The document also covers marketing strategies over the different stages of the product lifecycle from introduction to growth, maturity, and decline. Finally, it discusses elements of the pharmaceutical marketing mix including product, price, promotion, and place.
This document provides information on standard operating procedures (SOPs) for manufacturing equipment used in liquid, solid, and semi-solid dosage forms. It discusses what an SOP is, the objectives and benefits of SOPs, types of SOPs, SOP writing style, important points to consider when writing SOPs, and common equipment used to prepare liquid and semi-solid formulations. The document emphasizes that SOPs are essential for ensuring consistent, compliant production operations and for training personnel. They help maintain quality control and assure regulatory compliance.
This document discusses pharmaceutical sales and marketing in Pakistan. It covers various topics such as pharmaceutical company departments, product marketing and sales, distribution channels, and the job profile of a healthcare sales executive or medical representative. Specifically, it describes the marketing and promotions strategy at different levels including the doctor level, chemist level, patient level, and internally within sales and product management teams. It also provides details on pharmaceutical product detailing and the basic structure and contents of sales presentations to doctors.
“Marketing 2.0” in the pharmaceutical industry is no longer about just saying that our product is different and hoping customers will see it that way. It’s very much about making it so and then about finding our way to engage customers in a “conversation” that helps create the value rather than just promoting it through armies of medical representatives. We need to develop new, end-to-end processes that shape our relationships with physicians, payers, patients and care-givers.
This document provides a brand plan for PRO PL, a nutritional supplement brand, from 2018-2020. It outlines the target customer as pregnant women and women of childbearing age. The brand aims to provide overall nourishment to mothers and fetuses. Key insights indicate issues like pregnancy induced hypertension affect many pregnancies annually in India. The document reviews the nutritional supplements market and competitors. PRO PL is currently the second ranked brand in its niche segment. The brand vision is to become the most prescribed brand in its category, with an objective to reach 100 crore rupees in sales by 2020.
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medixambitbiomedix12
If you are looking to many types of Marketing Strategies in Pharma Sector then Ambit Bio Medix is one of best top 10 pharma franchise companies at the best price. Here are the Many Types of Marketing Strategies in Pharma Sector.
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
This document outlines the brand plan for Globifer for 2018/19. It includes insights on target customers, functional and emotional benefits, and opportunities in the iron deficiency market. The brand objectives are to attain 2% market share and be the most prescribed brand in its niche segment. The marketing strategy involves medical education programs, patient education, symposia, and a Royal College of Physicians accreditation program targeting 3000 doctors. The budget allocates funds towards visual aids, literature, samples, and activities over the fiscal year.
This document outlines the business plan for Losartan Potassium (LOSART) for 2015. It summarizes that hypertension prevalence in Bangladesh is approximately 20% according to different sources. The cardiovascular drug market is valued at 988 crores with antihypertensives comprising 636 crores. LOSART has a 29.24% share of the antihypertensive market as the second most prescribed generic. The plan identifies opportunities to increase market share by focusing on specialty physicians and improving performance in metro areas. Objectives for 2015 include achieving 10% growth, a 4.9% market share, and reaching the number 3 market position.
This document summarizes different drugs used for treating diabetes. It discusses the types of diabetes, mechanisms and types of insulin preparations including rapid-acting, intermediate-acting, and long-acting insulins. It also covers oral antidiabetic drugs like sulfonylureas, meglitinides, DPP-4 inhibitors, metformin, thiazolidinediones, alpha-glucosidase inhibitors, and SGLT-2 inhibitors; describing their mechanisms of action, pharmacokinetics and adverse effects. It concludes by listing common oral hypoglycemic agents and their usual daily doses and frequencies.
This document provides a brand plan for the launch of KOF-FREE, a combination drug containing salbutamol, ambroxol, and guaifenesin. The brand plan outlines the total market size and growth rate for the drug category. It analyzes competitors and sets sales targets for the launch year. The promotional strategy includes visual aids, samples, and activities targeting pediatricians, chest specialists, and general practitioners. Financial projections estimate first year sales of Rs. 20.21 lakhs and profit after accounting for promotional expenses and costs. The long term objective is to gain 1% market share in the launch year and be a top 5 brand by 2020.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.Amruta Sonawane
This document summarizes key tests performed on pharmaceutical formulations, including content uniformity, hardness, and dissolution. Content uniformity testing ensures each tablet contains the intended amount of active drug with little variation between tablets. Hardness testing measures a tablet's crushing strength, with limits varying based on the type of tablet. Dissolution testing predicts in vivo drug release profiles using basket or paddle apparatus under set conditions to simulate gastrointestinal fluids. These tests help ensure consistent dosing, sufficient strength, and controlled drug release.
This document discusses quality control of medicinal products. It defines quality control as procedures to ensure identity and purity of pharmaceuticals, ranging from simple chemical tests to complex pharmacopoeial standards. The document outlines types of counterfeit medicines that may have incorrect ingredients or dosages. It also discusses analytical processes for quality control, including standard methods, field tests, and ensuring precision and accuracy. Quality assurance involves four phases from evaluating new methods to external audits.
Here are some key points to consider when managing a pharmaceutical product portfolio across the product life cycle:
- Balance pipeline, in-line, and mature products to ensure continuous revenue and profit streams as products move through stages of the PLC
- Allocate R&D, marketing resources appropriately based on products' stage in PLC
- Consider portfolio synergies - how products complement each other's markets, sales forces, etc.
- Manage patent expirations and generic competition for in-line products
- Continuously evaluate portfolio for gaps, underperformers, and divestment/acquisition opportunities
- Ensure pipeline has mix of early/late stage products and therapeutic areas for future growth
The goal is a balanced,
This document gives detailed information regarding the processes followed in a Pharma Manufacturing Company.
It also includes graphical representation, for easy understanding.
This document discusses marketing and sales roles in the pharmaceutical industry. It describes key marketing concepts like focusing on customer needs and influencing activities to reach the right customers. It also discusses different types of market research used in the industry like surveys of pharmacies and physicians to understand product usage and effectiveness of marketing activities. The document also covers sales roles like detailing to physicians and sample management, as well as other marketing techniques like using key opinion leaders and medical science liaisons.
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
April 18, 2017
In April we held a Network Forum on engaging policymakers and patients/public effectively and appropriately. We would like to give a warm thanks to both Carolyn Shimmin, Patient Engagement expert of CHI's Knowledge Translation team, and Marcia Thomson, Assistant Deputy Minister of Manitoba Health, Seniors and Active Living for their presentations. Below you can see Carolyn's presentation - to see more of her work on patient engagement and to learn more about knowledge translation at CHI, please check out the blog Knowledge Nudge here. If you would like more information, helpful tools or advice about patient/public engagement in research, please contact Carolyn Shimmin at cshimmin@exchange.hsc.mb.ca
Learn how to assess internal (research/project team) and external (patient/public partner) readiness to engage in health research.
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
• Describe the importance of conducting readiness assessments prior to engagement;
• Describe key concepts for assessing internal and external readiness; and
• Conduct readiness assessments in planning patient engagement.
ROLE & RESPONSIBILITIES OF A MEDICAL REPRESENTATIVE.pptxManish13261326
The document discusses the role and responsibilities of a medical representative. Their key responsibilities include achieving sales targets, promoting products to doctors and retailers, identifying new business opportunities, providing product knowledge and feedback from customers. Medical representatives must have excellent communication, presentation, and interpersonal skills. They are expected to build brands, generate prescriptions and establish good relationships with customers. The document also outlines the expectations that doctors have of pharmaceutical companies, such as regular visits, scientific information and satisfying patient needs. Medical representatives use various promotional methods like visual aids, literature, samples and gifts to promote pharmaceutical products.
This document discusses strategies for launching new pharmaceutical brands. It outlines that successful product launching depends on coordination across functions. The purpose is to build sales. A launching strategy consists of marketing decisions, activities, and product attributes to present the product to its target market. The objectives are to generate income. Key aspects of launching strategy include being first to market, a first follower, or delayed entrant. Marketing decisions include market entry strategy, product positioning, and marketing mix. Strategic decisions involve company strategy, product strategy, market strategy, and competitive strategy. Tactical decisions involve the marketing mix of product, price, promotion, and distribution. Success depends on customer performance, financial performance, and technical performance. The document provides details on various strategic
This document discusses various marketing strategies for pharmaceutical products. It begins with defining key terminology related to drugs, such as generic, branded, patented, and over-the-counter medicines. It then outlines general marketing strategies such as market expansion, market share growth, niche markets, and market exit. Specific strategies for market leaders, challengers, followers, and niche players are also discussed. The document also covers marketing strategies over the different stages of the product lifecycle from introduction to growth, maturity, and decline. Finally, it discusses elements of the pharmaceutical marketing mix including product, price, promotion, and place.
This document provides information on standard operating procedures (SOPs) for manufacturing equipment used in liquid, solid, and semi-solid dosage forms. It discusses what an SOP is, the objectives and benefits of SOPs, types of SOPs, SOP writing style, important points to consider when writing SOPs, and common equipment used to prepare liquid and semi-solid formulations. The document emphasizes that SOPs are essential for ensuring consistent, compliant production operations and for training personnel. They help maintain quality control and assure regulatory compliance.
This document discusses pharmaceutical sales and marketing in Pakistan. It covers various topics such as pharmaceutical company departments, product marketing and sales, distribution channels, and the job profile of a healthcare sales executive or medical representative. Specifically, it describes the marketing and promotions strategy at different levels including the doctor level, chemist level, patient level, and internally within sales and product management teams. It also provides details on pharmaceutical product detailing and the basic structure and contents of sales presentations to doctors.
“Marketing 2.0” in the pharmaceutical industry is no longer about just saying that our product is different and hoping customers will see it that way. It’s very much about making it so and then about finding our way to engage customers in a “conversation” that helps create the value rather than just promoting it through armies of medical representatives. We need to develop new, end-to-end processes that shape our relationships with physicians, payers, patients and care-givers.
This document provides a brand plan for PRO PL, a nutritional supplement brand, from 2018-2020. It outlines the target customer as pregnant women and women of childbearing age. The brand aims to provide overall nourishment to mothers and fetuses. Key insights indicate issues like pregnancy induced hypertension affect many pregnancies annually in India. The document reviews the nutritional supplements market and competitors. PRO PL is currently the second ranked brand in its niche segment. The brand vision is to become the most prescribed brand in its category, with an objective to reach 100 crore rupees in sales by 2020.
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medixambitbiomedix12
If you are looking to many types of Marketing Strategies in Pharma Sector then Ambit Bio Medix is one of best top 10 pharma franchise companies at the best price. Here are the Many Types of Marketing Strategies in Pharma Sector.
Novartis is a global healthcare company headquartered in Switzerland that employs over 115,000 people worldwide. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. Novartis operates in India through four entities and has a presence in pharmaceuticals, generics, vaccines, consumer health, eye care, and animal health. Some of Novartis' most visible and successful products include the diabetes drug Galvus, the hypertension drug Diovan, and the anticonvulsant Tegretol.
This document outlines the brand plan for Globifer for 2018/19. It includes insights on target customers, functional and emotional benefits, and opportunities in the iron deficiency market. The brand objectives are to attain 2% market share and be the most prescribed brand in its niche segment. The marketing strategy involves medical education programs, patient education, symposia, and a Royal College of Physicians accreditation program targeting 3000 doctors. The budget allocates funds towards visual aids, literature, samples, and activities over the fiscal year.
This document outlines the business plan for Losartan Potassium (LOSART) for 2015. It summarizes that hypertension prevalence in Bangladesh is approximately 20% according to different sources. The cardiovascular drug market is valued at 988 crores with antihypertensives comprising 636 crores. LOSART has a 29.24% share of the antihypertensive market as the second most prescribed generic. The plan identifies opportunities to increase market share by focusing on specialty physicians and improving performance in metro areas. Objectives for 2015 include achieving 10% growth, a 4.9% market share, and reaching the number 3 market position.
This document summarizes different drugs used for treating diabetes. It discusses the types of diabetes, mechanisms and types of insulin preparations including rapid-acting, intermediate-acting, and long-acting insulins. It also covers oral antidiabetic drugs like sulfonylureas, meglitinides, DPP-4 inhibitors, metformin, thiazolidinediones, alpha-glucosidase inhibitors, and SGLT-2 inhibitors; describing their mechanisms of action, pharmacokinetics and adverse effects. It concludes by listing common oral hypoglycemic agents and their usual daily doses and frequencies.
This document provides a brand plan for the launch of KOF-FREE, a combination drug containing salbutamol, ambroxol, and guaifenesin. The brand plan outlines the total market size and growth rate for the drug category. It analyzes competitors and sets sales targets for the launch year. The promotional strategy includes visual aids, samples, and activities targeting pediatricians, chest specialists, and general practitioners. Financial projections estimate first year sales of Rs. 20.21 lakhs and profit after accounting for promotional expenses and costs. The long term objective is to gain 1% market share in the launch year and be a top 5 brand by 2020.
TESTS ON FORMULATIONS: Content Uniformity, Hardness, Dissolution.Amruta Sonawane
This document summarizes key tests performed on pharmaceutical formulations, including content uniformity, hardness, and dissolution. Content uniformity testing ensures each tablet contains the intended amount of active drug with little variation between tablets. Hardness testing measures a tablet's crushing strength, with limits varying based on the type of tablet. Dissolution testing predicts in vivo drug release profiles using basket or paddle apparatus under set conditions to simulate gastrointestinal fluids. These tests help ensure consistent dosing, sufficient strength, and controlled drug release.
This document discusses quality control of medicinal products. It defines quality control as procedures to ensure identity and purity of pharmaceuticals, ranging from simple chemical tests to complex pharmacopoeial standards. The document outlines types of counterfeit medicines that may have incorrect ingredients or dosages. It also discusses analytical processes for quality control, including standard methods, field tests, and ensuring precision and accuracy. Quality assurance involves four phases from evaluating new methods to external audits.
Here are some key points to consider when managing a pharmaceutical product portfolio across the product life cycle:
- Balance pipeline, in-line, and mature products to ensure continuous revenue and profit streams as products move through stages of the PLC
- Allocate R&D, marketing resources appropriately based on products' stage in PLC
- Consider portfolio synergies - how products complement each other's markets, sales forces, etc.
- Manage patent expirations and generic competition for in-line products
- Continuously evaluate portfolio for gaps, underperformers, and divestment/acquisition opportunities
- Ensure pipeline has mix of early/late stage products and therapeutic areas for future growth
The goal is a balanced,
This document gives detailed information regarding the processes followed in a Pharma Manufacturing Company.
It also includes graphical representation, for easy understanding.
This document discusses marketing and sales roles in the pharmaceutical industry. It describes key marketing concepts like focusing on customer needs and influencing activities to reach the right customers. It also discusses different types of market research used in the industry like surveys of pharmacies and physicians to understand product usage and effectiveness of marketing activities. The document also covers sales roles like detailing to physicians and sample management, as well as other marketing techniques like using key opinion leaders and medical science liaisons.
Patient Engagement Presentation - MPN Network Forum April 18, 2017Alexandra Enns
April 18, 2017
In April we held a Network Forum on engaging policymakers and patients/public effectively and appropriately. We would like to give a warm thanks to both Carolyn Shimmin, Patient Engagement expert of CHI's Knowledge Translation team, and Marcia Thomson, Assistant Deputy Minister of Manitoba Health, Seniors and Active Living for their presentations. Below you can see Carolyn's presentation - to see more of her work on patient engagement and to learn more about knowledge translation at CHI, please check out the blog Knowledge Nudge here. If you would like more information, helpful tools or advice about patient/public engagement in research, please contact Carolyn Shimmin at cshimmin@exchange.hsc.mb.ca
Learn how to assess internal (research/project team) and external (patient/public partner) readiness to engage in health research.
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
• Describe the importance of conducting readiness assessments prior to engagement;
• Describe key concepts for assessing internal and external readiness; and
• Conduct readiness assessments in planning patient engagement.
This document provides guidance on recruiting patient and public partners for research engagement. It discusses important considerations around language and inclusion. Key aspects of developing a recruitment strategy are described, such as determining the purpose and goals of engagement and identifying motivations, roles and time commitments. The document provides a template for a call for patient partners, covering project details, the engagement opportunity, responsibilities, timelines, and contact information. It also offers tips for recruitment methods, screening applicants, and tips for successful engagement.
Co-design is a relationship where professionals and citizens share power to plan and deliver support together, recognising that both partners have vital contributions to make in order to improve quality of life for people and communities.
PE101: Introduction to Patient Engagement in Health ResearchCHICommunications
The document introduces patient engagement and the PREPPP award launch. It defines patient-oriented research as research engaged conducted with patients as partners that focuses on patient priorities and aims to improve outcomes and healthcare. Patient engagement means the meaningful involvement of patients in the governance, priority-setting, conduct, and knowledge translation of research. It discusses why engagement is important to ensure research addresses issues important to patients and improves outcomes. It also outlines levels of engagement from passive to active collaborative partnerships and provides resources for learning more about patient engagement.
This document provides a toolkit for patient and public partnership. It includes guidance on identifying opportunities for improvement through patient feedback, determining which patients to involve, defining partnership activities, and choosing appropriate approaches. The toolkit emphasizes establishing clear objectives and managing expectations when planning partnership activities. It also signposts to additional resources on existing patient experience data and legal requirements for consultation.
This session—delivered on March 1, 2024—aims to provide prospective applicants useful information about the Preparing for Research by Engaging Public and Patient Partners (PREPPP) Awards.
Topics include eligibility and assessment criteria, overall quality, and information about the Dr. Wattamon Srisakuldee Memorial PREPPP Award.
Endocrine Society's content strategy, guided by Content Company: How they knew they needed a content strategy, the steps they took to prioritize goals, better understand the audience, and improve the content and presentation, and what the outcomes were.
Better Healthcare Through Community and Stakeholder Engagement, 2015 Webinar ...Paul Gallant
"An enjoyable presentation, well-delivered with excellent insight into community and stakeholder engagement strategies. Terry Dyni - July 23, 2015" on the webinar version. This version is my complete slide deck from a live webinar presentation requested by the Conference Board of Canada. April, 2015. Thanks for your interest in Better Healthcare Through Community and Stakeholder Engagement.
Compliments of Paul W. Gallant, CHE, GALLANT HEALTHWORKS & Associates (GHWA), Vancouver, BC, Canada. PS See the last slide for contact details or to arrange customized training/facilitation or advice on your organizational needs.
Why Patient Engagement Matters in Data Science, Engineering and TechnologyCHICommunications
This presentation, delivered on February 28, 2024, discusses and defines patient-oriented research as it relates to the fields of data science, engineering and technology.
Participants also learned about CHI's annual Preparing for Research by Engaging Patient and Public Partners (PREPPP) award.
chimb.ca
1) Advocacy is defined as a process to influence policy and decision makers through strategically using information to change policies that affect disadvantaged groups. It involves changing attitudes, actions, policies, and laws by influencing powerful individuals and organizations.
2) Successful advocacy requires getting to know key players, committees, and decision makers. It also involves creating strategic alliances, anticipating opposition strategies, and using media strategically.
3) Effective advocacy planning identifies influencers and decision makers, understands their perspectives, and develops evidence-based messages and promotion strategies tailored to specific audiences.
Communicating Research to the Real World through News Media and MoreKara Gavin
A presentation about interacting with news media, institutional communicators and general audiences directly, created for the CHOP Fellows at the University of Michigan, October, 2020
The document discusses the Right Here initiative, a 5-year pilot program funded by MHF and PHF to improve mental health services for youth ages 16-25 in Brighton and Hove, UK. It is being run by Sussex Central YMCA and Mind in Brighton and Hove through resilience activities, campaigns, peer research, and fast-track counseling. It also details work being done with GPs, including youth research on experiences with GP services, assessment visits to GPs to provide best practices, and developing digital tools like "Doc Ready" and "My Places" to help prepare youth for doctor visits and find local mental health resources.
Do you need help with quality appraisal of different types of non-research evidence? This webinar will walk you through case examples showing how to use NCCMT’s Quality Assessment of Community Evidence (QACE) and Resource Planning and Assessment (RPA) tools to assess the quality of contextual evidence, including local health issues, community and political preferences and actions, and financial and human resources. Alongside the webinar, we are offering Knowledge Brokering mentorship to support post-webinar use of the tools.
Considering applying for CHI's Preparing for Research by Engaging Patient and Public Partners (PREPPP) Award? Check out this slide deck of tips & suggestions for your application.
More info at www.chimb.ca/preppp
This document summarizes a workshop held by the Patient-Centered Outcomes Research Institute (PCORI) to solicit research topic recommendations from patients and stakeholders. The workshop provided information on PCORI's mission and research prioritization process. Participants engaged in breakout sessions to recommend topics and provide feedback on PCORI's stakeholder engagement strategies and prioritization methodology. PCORI aims to fund high-quality, patient-centered outcomes research to help patients make informed healthcare decisions.
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Understand the importance of strategic planning for research uptake
- Familiarise key aspects of a research uptake strategy
- Develop research uptake objectives for your research group, project, hub or an event
- Identify key stakeholders using stakeholder analysis techniques
- Review communications channels, outputs and activities
- Explore indicators and tools for monitoring and evaluation
- Key questions to consider in a research uptake strategy
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
This presentation features key information about CHI's Preparing for Research by Engaging Public & Patient Partners (PREPPP) Award including eligibility criteria, key dates, and application package information.
This document discusses involving children and young people in health and social care research. It provides context on policies supporting their involvement. Benefits include research being more relevant and findings more accessible, while challenges include logistics, ethics, and ensuring meaningful participation. Principles for effective involvement include planning at all stages, obtaining informed consent, providing training and support, and evaluating impact. Creative methods and involving youth in evaluation can help overcome challenges.
Similar to Tips and Tricks for Establishing a Patient Advisory Group (20)
Navigating Conflict in PE Using Strengths-Based ApproachesCHICommunications
Delivered on May 15, 2024 by the public and patient engagement team from the George & Fay Yee Centre for Healthcare Innovation, this presentation discusses the nuances of navigating conflict in patient engagement.
Learning objectives include:
-Understand the importance of using a trauma-informed approach in patient and public engagement
-Develop a strategy to work with patient and public partners in addressing conflict as it arises
-Employ strengths-based approaches to plan for conflict in your own work
Community Engagement of Sexual & Gender Minority PopulationsCHICommunications
This session, tailored for intermediate learners, offers a deep dive into patient and community engagement in health research, specifically focusing on its pivotal role in driving policy change. Learners will emerge equipped with:
🟠 A comprehensive understanding of the benefits of patient and community engagement in health research.
🟠 The ability to articulate the principles of authentic patient and community engagement.
🟠 A clear definition of intersectionality and practical insights into incorporating its principles into their patient and community engagement strategies.
🟠 An appreciation for the pivotal role of advocacy and the development of public- and stakeholder-facing materials in research programs aimed at influencing health policy.
Engaging with First Nations women with experiences of breast cancerCHICommunications
Objectives
• To learn about the impact and meaningfulness of storytelling approaches for patient engagement and decolonizing research
• To understand the importance of using Indigenous research methods, such as storytelling, in health research
• To critically reflect on engagement approaches for respectful research in Indigenous health research
This presentation by CHI's Public & Patient Engagement Lead Carolyn Shimmin describes the importance of trauma-informed engagement in health research projects.
Book your free consultation at chimb.ca
This document discusses patient-oriented research and patient engagement in health research. It defines patient-oriented research as research that engages patients as partners, focuses on patient priorities, improves outcomes, and aims to apply knowledge to improve healthcare. Patient engagement is defined as meaningful involvement of patients in governance, priority-setting, conducting, and knowledge translation of research. The document outlines guiding principles of engagement, why engagement is important, levels of engagement, and tools/resources to support engagement. It emphasizes inclusion of diverse voices and conducting research with patients, not on them.
This document provides guidance on effectively engaging children and youth in research. It discusses:
1) Planning activities to start groups off well by separating youth from adults, keeping questions simple, and not judging responses.
2) Practices to avoid like long introductions, power imbalances, and sensitive questions too early.
3) Tips for successful engagement including explaining research simply, showing passion, encouraging questions, keeping attention with varied activities, and listening to feedback.
Developing a Provincial Patient and Family Advisor NetworkCHICommunications
Introductory session on the collaborative planning process that Shared Health’s Public, Patient, and Family Engagement Team led, with patient and family advisors and engagement staff from across the province, to develop a provincial network of advisors.
Join us to learn about the collaborative planning process for the Manitoba Provincial Patient and Family Advisor Network, and how engagement staff can access the Network to help recruit advisors for their projects. We will also share what provincial projects we have been working on and what we see for the future.
Objectives:
• Describe key steps in a collaborative and engaging planning process;
• Discuss current and future engagement initiatives in Manitoba; and
• Use the services of the Patient and Family Advisor Network.
Navigating Conflict in PE Using Strengths-Based ApproachesCHICommunications
Led by CHI's Patient Engagement team, this session is intended to teach users how to deal with and prepare for conflict as it arises in patient engagement.
Patient Engagement for Data Science, Technology & EngineeringCHICommunications
Learn the necessities and relationship between patient engagement and data science, engineering and technology.
Presented by Trish Roche, CHI's Knowledge Translation Practice Lead, this presentation is geared towards professionals in data science looking to hone their skills in patient engagement.
This intermediate session looks at how physical presence and performance can influence engagement in health research services.
By the end of this session, learners should be able to describe the concept of critical reflexivity, describe the concept of embodied reflexivity, and discuss why bodies matter in patient and public engagement.
This document discusses levels of engagement and appropriate methods for patient and public engagement in research. It outlines three levels of engagement from lowest to highest: consultation, collaboration, and user-directed. Consultation involves obtaining feedback or input with decision-making power lying with researchers. Collaboration actively partners with patients/caregivers with shared decision-making. User-directed has patients/caregivers control the research process with decision-making power lying with them. It provides examples of engagement methods that correspond to each level and important considerations for each level. The document aims to help attendees understand different engagement levels and find methods in CHI's engagement guide for a given level of their own projects.
Showing Appreciation & Building Meaningful RelationshipsCHICommunications
Learning Objectives:
- Describe methods for meaningful relationship-building
- Discuss challenges & opportunities for implementing appreciation guidelines in your own work
- Implement methods for appreciation beyond financial compensation
This document outlines Manitoba's provincial patient-reported measurement strategy. It defines patient-reported measures and their role in patient-centered care. The strategy was developed with input from patients and the public. A provincial advisory committee with patient representatives was formed. Consultations ensured cultural and linguistic appropriateness. Valid and reliable tools will be selected and data collected electronically to integrate with health records. Results will be reported back clearly to enhance care and be understood by patients and clinicians.
Grand Round: RITHIM — A New Approach to Research in ManitobaCHICommunications
Research Improvements Through Harmonization in Manitoba (RITHIM) is the next step in streamlining and improving the research process. Together, we can improve the lives of Manitobans.
This case study by PREPPP Award winner Dr. Anna Chudyk and her team discusses experiences, lessons learned, and barriers and facilitators to engaging in health research scoping reviews.
Dr. Dylan MacKay shares his experiences in early engagement in clinical trials.
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Learn about the use of focus and discussion groups to engage and/or collect data with patients, the public, and research participants.
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
- Describe differences between focus groups and discussion groups;
- Determine when each approach is appropriate to use; and
- Assess challenges and needs for planning effective focus and discussion groups.
This document discusses considerations for budgeting patient engagement. It outlines learning objectives around key engagement considerations, barriers and facilitators to virtual engagement, and using a budget builder tool. It then covers compensation and reimbursement for patient partners, including forms of compensation, resources on guidelines, and Canada Revenue Agency information. Finally, it directs readers to a budget building tool and additional resources.
CHI's Lunchtime Learning is open to all researchers, decision-makers, clinicians, patients and members of the public who want to learn more about the theory and practice of meaningful, inclusive, and safe patient and public engagement.
Following this session, attendees should be able to:
Describe the theoretical foundations of the Valuing All Voices framework;
Describe methods used in co-development of the framework; and
Apply the framework to development of a patient engagement strategy for health research and services projects and/or programs.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
2024 HIPAA Compliance Training Guide to the Compliance OfficersConference Panel
Join us for a comprehensive 90-minute lesson designed specifically for Compliance Officers and Practice/Business Managers. This 2024 HIPAA Training session will guide you through the critical steps needed to ensure your practice is fully prepared for upcoming audits. Key updates and significant changes under the Omnibus Rule will be covered, along with the latest applicable updates for 2024.
Key Areas Covered:
Texting and Email Communication: Understand the compliance requirements for electronic communication.
Encryption Standards: Learn what is necessary and what is overhyped.
Medical Messaging and Voice Data: Ensure secure handling of sensitive information.
IT Risk Factors: Identify and mitigate risks related to your IT infrastructure.
Why Attend:
Expert Instructor: Brian Tuttle, with over 20 years in Health IT and Compliance Consulting, brings invaluable experience and knowledge, including insights from over 1000 risk assessments and direct dealings with Office of Civil Rights HIPAA auditors.
Actionable Insights: Receive practical advice on preparing for audits and avoiding common mistakes.
Clarity on Compliance: Clear up misconceptions and understand the reality of HIPAA regulations.
Ensure your compliance strategy is up-to-date and effective. Enroll now and be prepared for the 2024 HIPAA audits.
Enroll Now to secure your spot in this crucial training session and ensure your HIPAA compliance is robust and audit-ready.
https://conferencepanel.com/conference/hipaa-training-for-the-compliance-officer-2024-updates
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
2. • To identify research priorities
• To shape and clarify research question
• To select appropriate methods/co-design
• To co-create recruitment and information
materials for participants
• To identify meaningful outcomes
• To conduct data collection
• To interpret research findings
• To co-develop KT approaches/methods
Patient Engagement and Advisory
Groups
3. • What are the values and expectations of
people, families and communities living
with the health condition?
• What’s important to patients, informal
caregivers, families, friends and
communities?
• What level people expect to be
engaged in the research project and how
they would prefer to be involved?
Readiness to Engage - External
4. • To what extent does the research
team believe that patient engagement will
improve the outcome of the research?
• What is the potential for patient partners to
influence decision-making within the
research process?
• What is the likelihood the research team
will fully consider patient partner input?
• What resources are likely to be available
to support patient partner involvement?
Readiness to Engage - Internal
5. • Diversity of perspectives
• Consult/collaborate/user-driven
• Resources/timeline
• Feed off of each other’s ideas
• Community preference for engagement
• Connection
• Strengths and resiliency
• Social change
Why Choose an Advisory Group
Method for Engagement?
6. • Help people and communities living with the
health issue;
• Mean giving back to your community ;
• Aid in working towards improving the quality
of life not only for yourself, but others as well;
• Assist in improving the quality of care and
services not only for yourself, but others;
and/or
• Give you the opportunity to contribute your
valuable insights and perspectives on this
Why Patient Partners May Choose to
Engage:
7. • What patient engagement in the research
project is meant to achieve; and
• How patient partners might contribute to
decision-making in the research
process?
Purpose for Engagement
8. • Patient Partner Liaison
• Facilitation
• Administrative Support
• Audio/Visual/Tech Support
Resources Required - Staff
9. • Compensation for patient partners’ time, insight and
contributions to the project
• Food/beverages
• Transportation/Travel
• Childcare/Respite
• Accommodations
• Technology
• Accessible space
• Materials
• Printing
• Mailing
Resources Required - Financial
11. • Who is affected differently by the health
issue?
• Who has different access to health care
services associated with this health
condition?
• Where along the health journey are
patients at?
• How am I going to ensure a diversity of
perspectives on my advisory group?
Who to Recruit
12. • Project Title
• Lay Language Overview of Engagement
Opportunity
• Roles and Responsibilities
• Time Commitment and Duration
• Honorarium/Compensation and
Reimbursement
• Contact Information
Callout
13. How to Write a Callout for Patient and
Public Partners
http://umanitoba.ca/centre-for-healthcare-
innovation/sites/centre-for-healthcare-
innovation/files/2022-02/call-for-patient-
and-public-partners.pdf
14. • Health Researchers
• Clinicians
• Healthcare Consumer Organizations
• Community Organizations
• Social Media
• Newspapers
• Radio
• People with lived/living experience
• Information Session
• Attending Events
Ways to Recruit
15. • Contact information
• Equity, Diversity and Inclusion
• Why you’re interested and what you feel
you bring to the table
• Skills and experiences
• Availability
• Preferences on how to engage
• Preferences on where to engage
Application
16. • Introductions and overview of project
• Would you be willing to tell us a little bit
about yourself and your health
experiences? (only as much as you feel
comfortable)
• Why are you interested in becoming a
member of the advisory group?
• Do you have any experience being on an
advisory group, a board or any similar
initiatives? Research project?
Interview
17. • What would you say are your special
interests, or unique life experiences or skills
that you could contribute to an advisory
group?
• What kind of commitment could you make
to this position?
• Are there any days or times that work best
for you to meet?
• Anything else that you would like us to
know about you? Or anything you didn’t get
to say?
Interview
18. • How do you feel about our group/research team
continuing our work online?
• We want to make sure you are able to fully participate
online. Can you let me know if you have a device with
an internet connection?
• Are you able to use audio and video on your device?
• Are you comfortable using Zoom or WebEx, or is there
another way you prefer to connect?
• Are there any health or ability restrictions we need to
be aware of in order to ensure we are meeting your
needs?
Online Engagement
19. • Has your availability changed? What are the
best times to set up a meeting?
• Do you feel you have space in your home
where you are comfortable to freely share
your thoughts and ideas?
• Do you have any suggestions for ground
rules when meeting online?
• Do you have any questions for me or the
team?
• Is there anything else you would like to talk to
me about regarding engaging online?
Online Engagement
20. • Introductions/Acknowledgements
• Ice Breakers
• Overview of project
• Opportunities to engage
• Confidentiality
• Compensation
• Communication
Orientation
21. • Patient Engagement 101
• Trauma-informed engagement
• Anti-oppressive and anti-racism approaches
• Cultural safety
• Conflict resolution
• CIHR SPOR Foundations in Patient-Oriented
Research curriculum
• SPOR SUPPORT Unit Training
• OCAP Principles
• CIHR TCPS 2 – Chapter 9
• Manitoba Indigenous Cultural Safety Training
Training
22. Roche, P. et al. Valuing All Voices: refining a trauma-informed,
intersectional and critical reflexive framework for patient engagement in
health research using a qualitative descriptive approach. Res Involv
Engagem 6, 42 (2020). https://doi.org/10.1186/s40900-020-00217-2
Relationship Building
23. Readiness to Engage Workbook
http://umanitoba.ca/centre-for-healthcare-innovation/sites/centre-
for-healthcare-innovation/files/2021-11/readiness-to-engage-
workbook.pdf
24. • What research decisions can advisory
group members inform?
• Looking at the project timeline, when do
these decisions have to be made?
• What possible participatory approaches
might we use to engage advisory group
where they are at?
• How will we handle the in-between times?
Mapping Out Your Engagement
Strategy
25. • The Importance of Ice Breakers
• Conversations around Safe/Brave Spaces
• Guiding Principles
• Vision Statement
• Justice, Equity, Diversity and Inclusion
(JEDI) Statement
• List of Counselling Supports and
Resources
• Wrap-Up
Advisory Group Foundations
26. • One research decision per meeting
• Think about participatory approaches that
will allow members to fully contribute their
insight, knowledge and expertise
• Meet people where they are at
Advisory Group Decision-Making
32. IMPORTANCE OF SAFE SPACES
Physical Safety: Ensuring everyone feels safe
in the environment where we meet, as well as
our physical presence and actions.
Emotional & Psychological Safety:
Interpersonal communication (verbal & non-
verbal) needs to be respectful and empathetic.
Introduction
33. SAFE SPACES
• What does physical safety mean to you?
• What does it look like to you?
• What does it feel like to you?
• What does emotional /psychological safety
mean to you?
• What does it look like to you?
• What does it feel like to you?
Introduction
34. SAFE SPACES
• What does cultural safety mean to you?
• What does it look like to you?
• What does it feel like to you?
• What does spiritual safety mean to you?
• What does it look like to you?
• What does it feel like to you?
Introduction
35. GUIDING PRINCIPLES & VALUES
• Work together to create list
• Prominently displayed
• Review at start of each session
• Add or elaborate on principles
• Common language
Introduction
38. PURPOSE OF ENGAGEMENT
• Why patient & public partners were selected
to participate in engagement
• Roles and expectations (for both patient and
public partners and the research team)
• Anticipated outcomes of engagement
activities
• Timelines, potential challenges, benefits for
patient and public partners
Engageme
nt
39. THE RESEARCH STUDY
• Lay language
• Brief description of background
• How patient and public partners play an
important role in the research
Engageme
nt
40. OPPORTUNITIES TO ENGAGE
• What decisions patient and public partners
can be involved in making
• How contributions will be used and who will
make final decisions
• Commitment needed (frequency & duration)
• Compensation & reimbursement (e.g.
parking, food provided, child-minding,
mileage, etc.)
• Confidentiality
• Opportunities for ongoing/future engagement
Engageme
nt
41. BENEFITS & PREFERENCES
• How does engagement benefit partners
• What are your preferences?
– Scheduling of meetings (day/weekend/evening/etc.)
– Frequency of meetings
– Location of meetings
– Accommodations and addressing barriers to
engagement
– Dietary preferences and restrictions
– Communication
– Facilitation
Engageme
nt
44. • Earth: The valuable
experiential knowledge
brought by members
• Roots of tree: What we think
are the root causes of the
health issue
• Trunk: Dream big – what kind
of supports would you like to
see
• Branches: Looking at both
the roots and trees co-
Vision Statement – Adapted Tree of
Hope
45. • Justice – Dismantling barriers
• Equity – Allocating resources so everyone
has access to same opportunities
• Diversity – Differences between us based
on systems of power and oppression
• Inclusion – fostering sense of belonging by
valuing and amplifying voices traditionally
less heard
Justice, Equity, Diversity and
Inclusion Statement
49. Outcomes
• Write, draw, story telling, take a photo of
outcomes that are important to you
• Tree of Life exercise – branches being the
desired outcomes
• Appreciative Inquiry technique
50. Methods and Design
• Citizen jury technique
• Charrettes
• Study circles
• Participatory design
56. Methods of PE: A Guide
http://umanitoba.ca/centre-for-healthcare-
innovation/sites/centre-for-healthcare-
innovation/files/2021-11/methods-of-
patient-and-public-engagement-guide.pdf
57. Potential Outline
• Meetings #1 and #2 – Relationship
building – Guiding Principles, Vision
Statement, JEDI statement
• Meeting #3 – Priority-setting and
Research Question– Journey mapping
• Meeting #4 – Evaluation - Appreciative
Inquiry
• Meeting #5 – Design – Study circles and
asynchronous (participant information)
58. Potential Outline
• Meeting #6 – Interpretation - Storytelling
• Meeting #7 and #8 – Knowledge
Translation – Participatory Design
• Meeting #9 – Wrap Up and Next Steps
59. Additional Considerations
• Sandwich with icebreakers and wrap-up
• Communicate how advisory group informed each
research decision (feedback loop)
• Knowledge Translation phase often takes more than one
meeting
• Touch on Guiding Principles on a regular basis
• Consider mid-review evaluation to make sure that people
are feeling good about engagement, feeling heard and
valued
• Regular touch-base/debriefing with members
• Choice and relationship-building important
60. Important Qualities
• Courage and honesty
• Willingness to model
• Presence
• Caring
• Belief in Group Process
• Openness
• Nondefensiveness in Coping with
Criticism
61. Important Qualities
• Self-Awareness
• Willingness to try new things and
experiences
• Belief in strengths and resiliency
• Self care
• Sense of humour
• Creativity
• Personal dedication and commitment
Editor's Notes
Housekeeping: location of bathrooms, food available, etc.
Revise as needed based on planned activities – remember that although there are proposed times, it is important for patient and public partners to feel safe and heard and you may need to adjust times as you go through the ‘agenda’.
Welcome & Brief introduction – who the team is, what the purpose of the evening is
Guidance for land acknowledgements:
For University of Manitoba, see https://news.umanitoba.ca/acknowledging-traditional-territories/
For other Canadian locations, please see https://www.caut.ca/sites/default/files/caut-guide-to-acknowledging-first-peoples-and-traditional-territory-2017-09.pdf
Ensure icebreaker activities are appropriate, inclusive, and avoid re-traumatization. The intent is to find common ground and get people talking, but the focus should be positive.
SAMPLE ICEBREAKER - Please take a moment to look at this photograph and reflect what it means for you OR as you are observing what stands out for you. We will start introducing ourselves by saying our name and what we see in the picture, and then going around the circle until everyone has had the opportunity to share.
As you can see we were all looking the same photo, yet we all came up with something different based on our own perspectives. It’s important that when we are working together that we take into consideration all the different perspectives in order to create a holistic picture.
We wanted to start off by having a conversation about safety – what makes us feel safe. And the word “safety,” of course, can mean a lot of things. We can talk about physical safety – so is the place we are meeting here today, feel safe to everyone? It can also mean our own physical presence or actions (so sitting too close, leaning over, crossing arms, maybe certain things like this don’t make us feel safe). We also might mean emotional and psychological safety, so how we communicate with each other, both verbally but also non-verbally (for example eye rolling or turning away). It’s important for us to talk about what types of things make us feel safe and respected.
We’re going to look at each component of safety (i.e. physical, psychological, emotional, cultural, and spiritual) and ask the following questions:
What does “safety” mean to you?
What does “safety” look like to you?
What does “safety” feel like to you?
For facilitators, examples might be: Listening and not talking over top of each other, taking the time to understand and respect differing viewpoints, no shouting, allowing me time to process things, etc.
How does everyone feel about this list? Do you think we could use this list as our guide when we come together? Is there anything you would want to change or take out?
We’re going to look at each component of safety (i.e. physical, psychological, emotional, cultural, and spiritual) and ask the following questions:
What does “safety” mean to you?
What does “safety” look like to you?
What does “safety” feel like to you?
For facilitators, examples might be: Listening and not talking over top of each other, taking the time to understand and respect differing viewpoints, no shouting, allowing me time to process things, etc.
How does everyone feel about this list? Do you think we could use this list as our guide when we come together? Is there anything you would want to change or take out?
With the list
Facilitators – explain the difference between comfort and safety – you will be called out if you say something that is racist, sexist, ableist, homophobic, transphobic, classist, xenophobic, etc. – getting called out might feel uncomfortable, but that does not mean you are unsafe. In order to grow our trust and relationship, there may be times we need to challenge one another
Don’t be afraid to express your own reasons for becoming involved in this area of research, and why it is important to you on a personal level.
Patient-oriented research refers to a continuum of research that:
Engages patients as partners;
Focuses on patient-identified priorities;’
Improves patient outcomes;
Is conducted by multidisciplinary teams in partnership with relevant stakeholders; AND
Aims to apply the knowledge generated to improve healthcare systems and practices.